Childhood cancers trials in Netherlands

In Netherlands 120 Also abroad 2483

120 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Where
Utrecht
Age
Up to 25 years
People
210 worldwide
Run by
University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00
Phase 1/2Taking people
An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma
Where
Utrecht
Age
1 year to 18 years
People
22
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT07399821 · EU 2023-507596-22-00
Phase 1/2Taking people
A Multi-Arm, Platform Trial For Relapsed Neuroblastoma
Where
Utrecht
Age
1 year to 64 years
People
160 worldwide
Run by
University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00
No phaseTaking people
International Leukemia Target Board
Where
Utrecht
Age
0 years to 25 years
People
600 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05270096
No phaseTaking people
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
Where
Groningen
Age
16 years and over
People
20
Run by
University Medical Center Groningen
See details and how to joinNCT06769165
Phase 1/2Taking people
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Where
Utrecht
Age
1 year to 25 years
People
65 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT04925609 · EU 2024-513412-10-00
No phaseEnrolling by invitation
Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
Where
Amsterdam
Age
6 months to 35 years
People
240
Run by
Amsterdam University Medical Center
See details and how to joinNCT06227962
Phase 1Taking people
VyClo ITCC-092
Where
Utrecht
Age
Up to 64 years
People
25 worldwide
Run by
Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-508050-26-00
Phase 1/2Taking people
mFBG PET-CT for neuroblastoma
Where
Utrecht
Age
Up to 64 years
People
58
Run by
Princess Maxima Center For Pediatric Oncology
See details and how to join2022-501694-39-01
Phase 1/2Taking people
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Where
Utrecht
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00
Phase 1/2Taking people
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Utrecht
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01
Phase 1/2Taking people
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Where
Utrecht
Age
1 year to 21 years
People
26 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00
No phaseTaking people
Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node
Where
Rotterdam
Age
16 years and over
People
213
Run by
D.J. (Dirk) Grünhagen
See details and how to joinNCT06754904
Phase 3Taking people
CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients
Where
Utrecht
Age
1 day to 18 years
People
905
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05994690
Phase 2Taking people
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
Where
Utrecht
Age
1 month to 18 years
People
60 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01
No phaseTaking people
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Where
Deventer, Nijmegen
People
302 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06462963
Phase 1Taking people
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Where
Utrecht
Age
18 months to 18 years
People
38 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00
Phase 3Taking people
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Where
Groningen, Utrecht
Age
Up to 21 years
People
800 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00
No phaseTaking people
International Rare Histiocytic Disorders Registry (IRHDR)
Where
Utrecht
People
400 worldwide
Run by
The Hospital for Sick Children
See details and how to joinNCT02285582
No phaseEnrolling by invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
Where
Amsterdam, Groningen
Age
1 day and over
People
500 worldwide
Run by
Prof. Valérie Mc Lin
See details and how to joinNCT06041906
Phase 1/2Not yet taking people in Netherlands
The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies
Where
Utrecht
Age
1 year to 45 years
People
18
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT07020260 · EU 2023-507597-40-00
No phaseTaking people
Dutch Registry of Pediatric Cardiac Arrest
Where
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
Age
24 hours to 18 years
People
500
Run by
Matthijs de Hoog
See details and how to joinNCT06938009
Phase 2Taking people
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
Where
Utrecht
Age
6 months to 25 years
People
141 worldwide
Run by
Day One Biopharmaceuticals, Inc.
See details and how to joinNCT04775485 · EU 2024-510691-20-00
No phaseTaking people
Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia
Where
Amsterdam
Age
Up to 16 years
People
10,000 worldwide
Run by
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT06166706
No phaseTaking people
Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
Where
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
People
80
Run by
Maastricht University Medical Center
See details and how to joinNCT05463757